Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
This study has been completed.
Study NCT00214981   Information provided by Teva Pharmaceutical Industries

First Received on September 14, 2005.   Last Updated on July 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
ADHD
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
More general conditions related to this trial
Attention Deficit and Disruptive Behavior Disorders
Dyskinesias
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Modafinil
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Cephalon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services